GW’s Hematology and Medical Oncology Best Practices on Demand is the most comprehensive board review for physicians preparing to take the Hematology and Medical Oncology certification exams or those desiring a comprehensive update of hematology and medical oncology standards of … The Division of Oncology has played a major role in the growth and development of the SCC, both clinically and scientifically. Govindan was honored for his innovative research, including in genomics, aimed at developing better lung cancer therapies and improving patient outcomes. Education and Fellowship Training . The clinical trial included 331 patients, who were randomized to receive standard therapy plus the personalized vaccine or standard therapy plus a placebo. European Urology 2016 Jul 22 | WU Record 8/2/16, Foluso Ademuyiwa and her colleague Laura Beirut (Department of Psychiatry) are launching a major study in African-American women with breast cancer to learn whether their genetic risks are influenced by the same mutations that affect white women or are altogether different mutations. The Anheuser-Busch Foundation established the endowed chair in 2001. J. Evan Sadler, MD, PhD, became chief of the division in 2009. Ira Hall will serve as co-lead principal investigator of the new program. The researchers demonstrated that some protein alterations can be used to identify drugs that may work against some cancers. Medical oncologists treat patients with medications, including chemotherapy, in outpatient and inpatient settings for nearly all types of cancers. Studying mice, the researchers found the drug prevented graft-versus-host disease, a debilitating, sometimes lethal condition that develops when transplanted stem cells attack the body’s own organs or tissues. The grant will fund a clinical trial of the HER2 inhibitor neratinib in combination with fulvestrant in patients with metastatic breast tumors that have HER2 mutations and are estrogen-receptor positive. Stuart Kornfeld and Joel Picus. John R. Hess, M.D., MPH, FACP, FAAAS. In 1999, after the appointment of Kenneth Polonsky, MD, as the new Chairman of Medicine, Dr. DiPersio was named Chief, Division of Oncology, which consolidated the Divisions of BMT and Medical Oncology into one division. A major goal of the center is to launch a clinic that will follow healthy individuals with normal blood counts and mutations in key genes that are linked to MDS. The division has continued to support the education and career development of fellows and junior faculty. Located across the street from Harborview Medical Center, the Harborview Hematology/Oncology Clinic consults, evaluates and cares for patients with blood disorders, bleeding problems, hematologic cancer and solid tumors. WU Record 10/9/20 | Cell 2020 Oct 2, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has been recognized once again as a top U.S. cancer institution, based on a review of its research programs. Nature Medicine 2016 Jul 4 | WU Record 7/5/16, Examining databases of proteins’ 3-D shapes, a group led by Li Ding has identified more than 850 DNA mutations that appear to be linked to cancer. The investigators found that leukemia cells from patients who relapsed after transplant often had greatly reduced expression of genes that were involved with the recognition of cancer cells by the immune system and that interferon gamma could restore expression of these genes. WU Record 5/10/18, An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Jaebok Choi, John DiPersio and colleagues. The BMT Program has grown from 30 transplants per year and 10 inpatient transplant beds in 1994 to approximately 400 transplants per year and 90 inpatient transplant and leukemia beds. Faysal Haroun, MD is an Assistant Professor of Medicine in the Division of Hematology & Oncology at the GW School of Medicine & Health Sciences.He was awarded his Medical Degree from the American University of Beirut School of Medicine. Washington University oncologists at the Siteman Cancer Center devote their efforts to preventing, diagnosing and treating cancer. Homologous Recombination Deficiency Real-Time Clinical Assays, Ready or Not? Currently, the program is managed by Douglas Adkins (Director, Oncology Division) and Morey Blinder (Associate Director, Hematology Division). Nicole Brossier, M.D., PhD Dr. Brossier completed fellowship in 2019, and joined the faculty in the Division of Pediatric Hematology and Oncology at St. Louis Children’s Hospital/Washington University as a member of the Neuro- Oncology team. BMT’s clinical research program has also been extremely successful, currently offering patients over 40 clinical trials, accruing over 260 patients to therapeutic clinical trials in 2010. Our Pediatric Hematology/Oncology Fellowship Program offers participants an opportunity to be part of a unique, world-class research and care environment. Down-regulation of PCAT-14 is associated with a greater probability of metastatic progression, and this finding may help to determine the intensity of therapy in individual patients. To prepare the vaccine, a small amount of tumor tissue was exposed to the patient’s own immune cells (dendritic cells) to train them to seek out and destroy the tumor. Concise, portable, and user-friendly, The Washington Manual Hematology and Oncology Subspecialty Consult, 4th Edition, provides quick access to the essential information needed to evaluate a patient on a subspecialty consult service. Members of the Division of Oncology are leaders in national and international efforts (through NCI and NHRGI-funded projects) to fully decode mutations associated with initiation and progression of cancers, both hematologic and solid tumor. Stem Cell Reports 2017 Aug 8 | WU Record 7/27/17, Studying mice with breast tumors transplanted from patients, a group at Washington University led by Li Ding, in collaboration with colleagues at The Broad Institute of MIT and Harvard and Baylor College of Medicine, have analyzed the proteins present in these tumors. We are particularly proud that many of these trainees and junior faculty have developed international reputations during their time in the Division of Oncology and have assumed major leadership roles at other institutions, including: We have continued to train and recruit the best and the brightest who will play major roles as thought leaders in cancer care and cancer biology either here or at other outstanding Cancer Centers around the country. They showed how blocking the downstream effects of these mutations can lead to normal production of blood cells. The first planning grant for the Washington University National Cancer Institute (NCI)-Designated Cancer Center was funded in 1996. These "complex indels" appear to cluster in important cancer genes more often than can be attributed to random chance. The division has contributed to many advances in our care of cancer patients and the biology of their diseases. WU Record 7/29/16, David DeNardo, Andrea Wang-Gillam and their colleagues have shown that immunotherapy against pancreatic cancer can be effective when given in conjunction with focal adhesion kinase (FAK) inhibitors, drugs that break up the fibrous tissue in these tumors. By studying this group of patients, the investigators hope to understand the differences between those patients who go on to develop MDS and those who don’t. Board-certified in medical oncology and hematology, Dr. Zandberg received his medical degree from Jefferson Medical College in Philadelphia. Robert Barczewski, MBA, CMPE, after working for fourteen years in the Department of Medicine Business Office, was picked to be the first Administrator of the two divisions. It was the vision of the late Dr. Stanley Korsmeyer (June 8, 1951 - March 31, 2005) who sought to expand both clinical and translational programs in hematologic and solid tumor malignancies at Washington University School of Medicine. Studying a mouse model, they also identified a possible therapeutic strategy for this disease. This evaluation resulted in a nearly perfect score, earning Siteman the highest possible rating — exceptional — by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). Many are involved in “translational research”, meaning they conduct research studies, enabling many new treatments to be available as […] In the various inpatient and outpatient settings, hematology faculty provide expert primary and consultative care for patients with a diverse spectrum of benign and malignant blood-related disorders. The Medicine and Cell Biology researchers occupy adjacent space on the fifth floor of the McDonnell Sciences Research Building. John DiPersio, MD, PhD, a physician-scientist focusing on leukemia and transplantation biology, was recruited from the University of Rochester to become the new Chief of the Division of Bone Marrow Transplant. In 1994, the bone marrow transplant and medical oncology programs were transferred to the new Oncology Division. His research has laid the groundwork for precision medicine in cancer treatment, which uses the genetic makeup of a patient’s tumor and how it responds to therapy as a guide for how best to attack that specific patient’s disease. The program has grown to include twenty fellows, including several in a non-accredited program focusing on bone marrow transplantation and breast cancer research. Its purpose is to help doctors match cancer mutations found in patients’ tumors with drugs that target such genetic … We have recruited 19 faculty who either trained at Washington University or trained here and were junior faculty members at other institutions prior to returning to Washington University. Leukemia 2018 Apr 2 | WU Record 4/24/18, Researchers nationwide have reached a major milestone in describing the genetic landscape of cancer. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-Tissue Sarcoma? Korsmeyer, Tim Ley and John Atkinson joined together to establish and build these programs in 1994. Our faculty may specialize in Oncology, Hematology or both. The Hematology-Oncology Fellowship Training Program at the University of Washington is designed to develop academic physicians who are competent in clinical hematology/oncology and research. Over the ensuing decade, the Division of Oncology has experienced unprecedented growth in numbers of faculty and national visibility and has excelled both clinically and scientifically. The combined faculty in both divisions numbered only eight, two in BMT and six in Medical Oncology. The group presently has five medical Hematologists Oncologists and support staff of Laboratory technicians, pharmacy technicians, phlebotomists, and Oncology Nurses. Leuk Lymphoma 2020 Nov 2:1-3; [Epub ahead of print], A Personalized Prediction Model for Outcomes After Allogeneic Hematopoietic Cell Transplant in Patients With Myelodysplastic Syndromes, Biol Blood Marrow Transplant 2020 Nov;26(11):2139-2146, Geriatric Assessment and Quality of Life Changes in Older Adults With Newly Diagnosed Multiple Myeloma Undergoing Treatment, The Characteristics, Treatment Patterns, and Outcomes of Older Adults Aged 80 and Over With Multiple Myeloma, Cancer Therapy Shapes the Fitness Landscape of Clonal Hematopoiesis, Selective Targeting of Alpha4beta1 Integrin Attenuates Murine Graft Versus Host Disease, Epithelioid and Spindle Cell Rhabdomyosarcoma With FUS-TFCP2 or EWSR1-TFCP2 Fusion: Report of Two Cases, Brentuximab Vedotin Plus Nivolumab as First-Line Therapy in Older or Chemotherapy-Ineligible Patients With Hodgkin Lymphoma (ACCRU): A Multicentre, Single-Arm, Phase 2 Trial, A Clickable Probe for Versatile Characterization of S-Nitrosothiols, Palliative Single-Fraction Whole Liver Radiation Therapy for Diffuse Liver Metastases From Metastatic Merkel Cell Carcinoma, Multi-Institutional Analysis of Stereotactic Body Radiotherapy for Sarcoma Pulmonary Metastases: High Rates of Local Control With Favorable Toxicity, Telomere Dysfunction Activates p53 and Represses HNF4alpha Expression Leading to Impaired Human Hepatocyte Development and Function, Memory-Like Natural Killer Cells for Cancer Immunotherapy, Inadequate and Delayed Characterization of Cutaneous Reactions for FDA Approved Oncologic Drugs From 2011-2020 Leading to Medication Discontinuation, J Am Acad Dermatol 2020 Oct 23; [Epub ahead of print], A Phase II Study of Telisotuzumab Vedotin in Patients With c-Met-Positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-Study S1400K, NCT03574753), Clin Lung Cancer 2020 Oct 14; [Epub ahead of print], Landmark Trials in the Medical Oncology Management of Early Stage Breast Cancer, Evidence Favoring the Efficacy of Convalescent Plasma for COVID-19 Therapy, Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-Based Biological Therapy, Am J Surg Pathol 2020 Oct 30; [Epub ahead of print], Venous Thromboembolism in Multiple Myeloma Is Associated With Increased Mortality, Res Pract Thromb Haemost 2020 Sep 25;4(7):1203-1210, TDP-43 Dysfunction Results in R-Loop Accumulation and DNA Replication Defects, Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction, Beyond Just a Tight Fortress: Contribution of Stroma to Epithelial-Mesenchymal Transition in Pancreatic Cancer, Signal Transduct Target Ther 2020 Oct 30;5(1):249, Disparities in Treatment Patterns and Outcomes Among Younger and Older Adults With Newly Diagnosed Multiple Myeloma: A Population-Based Study, J Geriatr Oncol 2020 Oct 24; [Epub ahead of print], Phase 2 Study of Ruxolitinib and Decitabine in Patients With Myeloproliferative Neoplasm in Accelerated and Blast Phase, Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma, Clin Lymphoma Myeloma Leuk 2020 Oct 1; [Epub ahead of print], CAR-T Therapy in Solid Organ Transplant Recipients With Treatment Refractory Post Transplant Lymphoproliferative Disorder, Am J Transplant 2020 Oct 22; [Epub ahead of print], Isatuximab as Monotherapy and Combined With Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma, Radiation and Checkpoint Inhibitor Immunotherapy Lead to Long Term Disease Control in a Metastatic RCC Patient With Brain Metastases, A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients With Advanced Melanoma, Non-Small Cell Lung Cancer, or Bladder Cancer, TP53 Abnormalities Correlate With Immune Infiltration and Associate With Response to Flotetuzumab Immunotherapy in AML, Zanubrutinib Monotherapy for Patients With Treatment Naive Chronic Lymphocytic Leukemia and 17p Deletion, Haematologica 2020 Oct 13;Online ahead of print, Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights Into Stromal-Mediated Radioresistance, Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology, Clin Cancer Res 2020 Oct 15;26(20):5388-5399, Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial, Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States, JCO Oncol Pract 2020 Oct;16(10):e1169-e1180, Treatment Decision-Making in Acute Myeloid Leukemia: A Qualitative Study of Older Adults and Community Oncologists, Leuk Lymphoma 2020 Oct 11:1-12; [Epub ahead of print], Splicing Factor SF3B1 Promotes Endometrial Cancer Progression Via Regulating KSR2 RNA Maturation, Tumor Burden, Inflammation, and Product Attributes Determine Outcomes of Axicabtagene Ciloleucel in Large B-Cell Lymphoma, A Forgotten Friend: CCNU as Palliative Monotherapy in Relapsed Hodgkin Lymphoma, Leuk Lymphoma 2020 Oct 8:1-3; [Epub ahead of print], TGFbetaR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment, Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 2020 Oct 1;18(10):1385-1415, Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma, Clin Lymphoma Myeloma Leuk 2020 Oct;20(10):647-651, Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma, Clin Genitourin Cancer 2020 Oct;18(5):361-366, Clin Genitourin Cancer 2020 Oct;18(5):341-342, Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial, Clin Cancer Res 2020 Oct 1;26(19):5140-5152, A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) With Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer, Clin Cancer Res 2020 Oct 1;26(19):5129-5139, Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones, Clonal Hematopoiesis and Risk for Hematologic Malignancy, Older Adult Participation in Cancer Clinical Trials: A Systematic Review of Barriers and Interventions, CA Cancer J Clin 2020 Oct 1; [Epub ahead of print], T Follicular Helper Phenotype Predicts Response to Histone Deacetylase Inhibitors in Relapsed/Refractory Peripheral T-Cell Lymphoma, 10-Day Decitabine With Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukaemia: A Single-Centre, Phase 2 Trial, IFNL4 and Donor Selection for Matched Unrelated Donor Haematopoietic Stem-Cell Transplantation, Potential Impact of Consolidation Radiation Therapy for Advanced Hodgkin Lymphoma: A Secondary Analysis of SWOG S0816, Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia, Invest New Drugs 2020 Oct;38(5):1430-1441, Cooperating, Congenital Neutropenia-Associated Csf3r and Runx1 Mutations Activate Pro-Inflammatory Signaling and Inhibit Myeloid Differentiation of Mouse HSPCs, Initial and Consolidation Therapy for Younger Patients With Mantle Cell Lymphoma, Hematol Oncol Clin North Am 2020 Oct;34(5):861-870, Mechanisms of Resistance to CAR T Cell Therapies, TPL2 Enforces RAS-Induced Inflammatory Signaling and Is Activated by Point Mutations, J Clin Invest 2020 Jun 23; [Epub ahead of print], Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer, Mapping and Characterization of Structural Variation in 17,795 Human Genomes, Nature 2020 May 27; [Epub ahead of print], Potently Cytotoxic Natural Killer Cells Initially Emerge From Erythro-Myeloid Progenitors During Mammalian Development, Exploring the "Minimal" Structure of a Functional ADAMTS13 by Mutagenesis and Small-Angle X-Ray Scattering, Posttranscriptional Modulation of TERC by PAPD5 Inhibition Rescues Hematopoietic Development in Dyskeratosis Congenita, Mutation Clearance After Transplantation for Myelodysplastic Syndrome, N Engl J Med 2018 Sep 13;379(11):1028-1041, An "Off-The-Shelf" Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies, Board Review: Clinical Research Methodology, Head, Neck, Thyroid and CNS Cancer, Board Review: Genetics / Tumor Biology, Gynecologic Cancer. Jeff Ward and Chris Miller are members of a global consortium that has identified features of tumor neoantigens that trigger T cells to attack the cancer and leave healthy tissue untouched. Led by Li Ding and colleagues in the Departments of Surgery and Radiology, the research will focus on how breast cancer evolves in response to treatments and how some tumors develop resistance to these treatments. WU Record 11/6/17, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Of the 1,200 new patients placed on therapeutic clinical trials in the past year in the Siteman Cancer Center, the Oncology Division was responsible for over 1,050 accruals. The trained dendritic cells were then returned to the patient as a vaccine. A fourth SCC outpatient office in South County will be open soon. Hematology/Oncology Fellowship Program The combined hematology and medical oncology fellowship training program of the George Washington University School of Medicine and Health Sciences (GW SMHS) and the Washington Veterans Administration Medical Center (VAMC) developed an ongoing research training affiliation with the National Institutes of Health (NIH) more than 10 years ago. The grant, from the National Institutes of Health (NIH), funds a prestigious Specialized Program in Research Excellence (SPORE) in leukemia. The Division of Oncology is the newest division of the Department of Medicine. In 2008, Dr. Picus assumed management of the program, assisted by Hematology Division Chief, Dr. Evan Sadler. Specialties: Hematology, Hematology Oncology. J Dermatol 2020 Nov 7; [Epub ahead of print], A Phase I Trial of Temsirolimus and Erlotinib in Patients With Refractory Solid Tumors, Cancer Chemother Pharmacol 2020 Nov 6; [Epub ahead of print], Outcomes of Patients With Large B-Cell Lymphoma Progressing After Axicabtagene Ciloleucel, Cardio-Oncology Education and Training: JACC Council Perspectives, J Am Coll Cardiol 2020 Nov 10;76(19):2267-2281, Tolerability and Safety of EUS-Injected Adenovirus-Mediated Double-Suicide Gene Therapy With Chemotherapy in Locally Advanced Pancreatic Cancer: A Phase 1 Trial, Gastrointest Endosc 2020 Nov;92(5):1044-1052, TGF-Beta Suppresses Type 2 Immunity to Cancer, Tazemetostat in Advanced Epithelioid Sarcoma With Loss of INI1/SMARCB1: An International, Open-Label, Phase 2 Basket Study, Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients With PIK3CA-Mutant Cancers, Clin Cancer Res 2020 Nov 4; [Epub ahead of print], NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021, J Natl Compr Canc Netw 2020 Nov 2;18(11):1460-1467, Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 2020 Nov 2;18(11):1537-1570, Discovery of Driver Non-Coding Splice-Site-Creating Mutations in Cancer, Integration of Genomic Medicine in Pathology Resident Training, Am J Clin Pathol 2020 Nov 4;154(6):784-791, Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients With Relapsed Refractory Hodgkin Lymphoma, Clin Cancer Res 2020 Nov 1;26(21):5579-5587, Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance). Greater Washington Oncology Associates was started in 1990 to provide the highest level of care in Hematology and Oncology in the greater Washington D.C. metro area. WU Record 11/6/18, A study led by Matthew Christopher, Allegra Petti, Michael Rettig and Timothy Ley offers a potential explanation for why many AML patients experience a relapse after a stem cell transplant and suggests a therapeutic approach that may help to place relapsed patients back into remission. A phase 1 clinical trial to test the safety of FAK inhibitors in patients with advanced pancreatic cancer is underway. Origins of the Oncology Division The Division of Oncology is the newest division of the Department of Medicine. Other faculty members, including Elliott E. Abbey, MD, and Scot G. Hickman, MD, developed the Washington University hematology-oncology service at the St. Louis VA Hospital during the 1980s. The division has recruited over 80 faculty and has a staff that now exceeds 400. Our faculty, who enrolled over 750 patients to therapeutic clinical trials in the last 12 months, wrote nearly 40% of these studies. The aim is to better reflect the spectrum of human diversity around the world and make the reference genome a more useful tool for researchers. Li Ding, assistant director of The McDonnell Genome Institute at Washington University, and scientists from about 20 other institutions have completed the genetic analyses of more than 11,000 tumors from patients, spanning 33 types of cancer - all part of The Cancer Genome Atlas (TCGA) project. Tel: (202) 444-7036 Fax: (202) 444-7797 Email: Over 250 clinical trials are currently open and available to our patients through the Section of Medical Oncology. That grant enabled him to set out on a field of study that would lay the foundation for understanding cells' behavior in health and inherited diseases. The database, called CIViC, was designed by computational biologists Obi Griffith and Malachi Griffith. Khaddour K, Ansstas M, Visconti J, Ansstas G Ann Oncol 2021 Feb;32(2):279-280, Albany C, Dockter T, Wolfe E, Le-Rademacher J, Wagner-Johnston N, Einhorn L, Lafky JM, Smith E, Pachman D, Staff N, Ma C, Loprinzi CL, Costello BA Support Care Cancer 2021 Feb;29(2):833-840, Oppelt P, Ley JC, Worden F, Palka K, Maggiore R, Liu J, Adkins D Oral Oncol 2021 Jan 16;114:105164; [Epub ahead of print], Han X, Zhang S, Zhou DC, Wang D, He X, Yuan D, Li R, He J, Duan X, Wendl MC, Ding L, Niu B Brief Bioinform 2021 Jan 18; [Epub ahead of print], Chen SY, Sinha P, Last A, Ettyreddy A, Kallogjeri D, Pipkorn P, Rich JT, Zevallos JP, Paniello R, Puram SV, Van Abel K, Moore EJ, Oppelt P, Palka K, Adkins D, Daly M, Gay H, Thorstad WL, Jackson RS JAMA Otolaryngol Head Neck Surg 2021 Jan 1;147(1):16-22, Cortes J, Podoltsev N, Kantarjian H, Borthakur G, Zeidan AM, Stahl M, Taube T, Fagan N, Rajeswari S, Uy GL Int J Hematol 2021 Jan;113(1):92-99, Garcia-Manero G, Diez-Campelo M, Vellenga E, Jacoby MA, Merchan B, Breems D, Cortelezzi A, Doronin V, Gomez V, Beckers M, Porta MGD, Varsos H, Xiu L, DeAngelis N, Nnane I, Rose E, van Eygen K Am J Hematol 2021 Jan 15; [Epub ahead of print], Ailawadhi S, Frank R, Ailawadhi M, Kanji Z, Jani P, Fiala M, Abdulazeez M, Ahmed S, Aggarwal CS, Aulakh S, Hodge D, Roy V, Alegria VR, Paulus A, Chanan-Khan A, Sher T Ann Hematol 2021 Jan 12; [Epub ahead of print], Rimando JC, Christopher MJ, Rettig MP, DiPersio JF J Clin Oncol 2021 Jan 12:JCO2001587; [Epub ahead of print], Garon EB, Kim JS, Govindan R Lung Cancer 2021 Jan;151:25-29, Nair S, Mazzoccoli L, Jash A, Govero J, Bais SS, Hu T, Fontes-Garfias CR, Shan C, Okada H, Shresta S, Rich JN, Shi PY, Diamond MS, Chheda MG JCI Insight 2021 Jan 11;6(1), Verstovsek S, Chen CC, Egyed M, Ellis M, Fox L, Goh YT, Gupta V, Harrison C, Kiladjian JJ, Lazaroiu MC, Mead A, McLornan D, McMullin MF, Oh ST, Perkins A, Platzbecker U, Scheid C, Vannucchi A, Yoon SS, Kowalski MM, Mesa RA Future Oncol 2021 Jan 11; [Epub ahead of print], Kung CP, Cottrell KA, Ryu S, Bramel ER, Kladney RD, Bao EA, Freeman EC, Sabloak T, Maggi L Jr, Weber JD Oncogene 2021 Jan;40(1):189-202, Clinical Proteomic Tumor Analysis Consortium (Authors include: Wyczalkowski MA, Ding L) Cancer Cell 2021 Jan 5; [Epub ahead of print], Waqar SN, Govindan R J Clin Oncol 2021 Jan 8:JCO2003297; [Epub ahead of print], PDXNET Consortium (Authors include: Ding L, Li S, Govindan R) (Contributors include: Cao S, DiPersio JF, Lim KH, Ma CX, Van Tine BA, Wang-Gillam A, Wyczalkowski MA) Nat Genet 2021 Jan;53(1):86-99, Martin-Broto J, Pousa AL, Brohl AS, Van Tine BA, Powers B, Stacchiotti S, Blay JY, Hu JS, Oakley GJ 3rd, Wang H, Szpurka AM, Levy DE, Mo G, Ceccarelli M, Jones RL Mol Cancer Ther 2021 Jan;20(1):132-141, Covut F, Driscoll JJ, Cooper B, Gallogly M, De Lima M, Malek E Leukemia 2021 Jan;35(1):250-254, Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, de Lima M, Fathi AT, Foran JM, Gojo I, Hall AC, Jacoby M, Lancet J, Mannis G, Marcucci G, Martin MG, Mims A, Neff J, Nejati R, Olin R, Percival ME, Prebet T, Przespolewski A, Rao D, Ravandi-Kashani F, Shami PJ, Stone RM, Strickland SA, Sweet K, Vachhani P, Wieduwilt M, Gregory KM, Ogba N, Tallman MS J Natl Compr Canc Netw 2021 Jan 6;19(1):16-27, Zhang X, Detering L, Sultan D, Luehmann H, Li L, Heo GS, Zhang X, Lou L, Grierson PM, Greco S, Ruzinova M, Laforest R, Dehdashti F, Lim KH, Liu Y ACS Nano 2021 Jan 6; [Epub ahead of print], Dustin D, Gu G, Beyer AR, Herzog SK, Edwards DG, Lin H, Gonzalez TL, Grimm SL, Coarfa C, Chan DW, Kim BJ, De La O JP, Ellis MJ, Liu D, Li S, Welm AL, Fuqua SAW Br J Cancer 2021 Jan;124(1):191-206, Janku F, Zhang HH, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, Shepard DR, Helgason T, Masters T, Hong DS, Piha-Paul SA, Karp DD, Klang M, Huang SY, Sakamuri D, Raina A, Torrisi J, Solomon SB, Weissfeld A, Trevino E, DeCrescenzo G, Collins A, Miller M, Salstrom JL, Korn RL, Zhang L, Saha S, Leontovich AA, Tung D, Kreider B, Varterasian M, Khazaie K, Gounder MM Clin Cancer Res 2021 Jan 1;27(1):96-106, Galdieri L, Jash A, Malkova O, Mao DD, DeSouza PA, Chu YE, Salter A, Campian JL, Naegle KM, Brennan CW, Wakimoto H, Oh ST, Kim AH, Chheda MG JCI Insight 2021 Jan 5; [Epub ahead of print], Gerratana L, Davis AA, Polano M, Zhang Q, Shah AN, Lin C, Basile D, Toffoli G, Wehbe F, Puglisi F, Behdad A, Platanias LC, Gradishar WJ, Cristofanilli M Eur J Cancer 2021 Jan;143:147-157, Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ, Griffith M, Griffith OL, Wagner AH Nucleic Acids Res 2021 Jan 8;49(D1):D1144-D1151, Spigel DR, Jotte RM, Aix SP, Gressot L, Morgensztern D, McCleod M, Socinski MA, Daniel D, Juan-Vidal O, Mileham KF, West H, Page R, Reinmuth N, Knoble J, Chen T, Bhore R, Wolfsteiner M, Ong TJ, Gridelli C, Thomas M Clin Lung Cancer 2021 Jan;22(1):6-15e4, Cornell R, Hari P, Tang S, Biran N, Callander N, Chari A, Chhabra S, Fiala MA, Gahvari Z, Gandhi U, Godby K, Gupta R, Jagannath S, Jagosky M, Kang Y, Kansagra A, Kauffman M, Kodali S, Kumar SK, Lakshman A, Liedtke M, Lonial S, Ma X, Malek E, Mansour J, McGehee EF, Neppalli A, Paul B, Richardson P, Scott EC, Shacham S, Shah J, Siegel DS, Umyarova E, Usmani SZ, Varnado W, Vij R, Costa L Am J Hematol 2021 Jan;96(1):E5-E8, Khaddour K, Dowling J, Huang J, Council M, Chen D, Cornelius L, Johanns T, Dahiya S, Ansstas G Oncotarget 2020 Dec 29;11(52):4836-4844, Ahmed R, Covut F, Kewan T, Haddad A, Daw H Am J Ther 2020 Dec 29;Publish Ahead of Print; [Epub ahead of print], Kewan T, Covut F, Daw H, Haddad A Am J Ther 2020 Dec 29;Publish Ahead of Print; [Epub ahead of print], Genois MM, Gagne JP, Yasuhara T, Jackson J, Saxena S, Langelier MF, Ahel I, Bedford MT, Pascal JM, Vindigni A, Poirier GG, Zou L Mol Cell 2020 Dec 30; [Epub ahead of print], Harding JJ, Kelley RK, Tan B, Capanu M, Do GK, Shia J, Chou JF, Ferrer CS, Boussayoud C, Muenkel K, Yarmohammadi H, El Dika I, Khalil DN, Ruiz C, Rodriguez-Lee M, Kuhn P, Wilton J, Iyer R, Abou-Alfa GK Oncologist 2020 Dec;25(12):e1825-e1836, Ellebedy A, Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, Hansen L, Haile A, Klebert M, Pusic I, O'Halloran J, Presti R Res Sq 2020 Dec 31, Russler-Germain DA, Kahl BS Oncology (Williston Park) 2020 Dec 7;34(12):522-534, Li Y, Miller CA, Shea LK, Jiang X, Guzman MA, Chandler RJ, Ramakrishnan SM, Smith SN, Venditti CP, Vogler CA, Ory DS, Ley TJ, Sands MS Mol Ther 2020 Dec 31; [Epub ahead of print], Guo Z, Primeau T, Luo J, Zhang C, Sun H, Hoog J, Gao F, Huang S, Edwards DP, Davies SR, Aft R, Ding L, Ellis MJ, Li S, Ma CX Cancers (Basel) 2020 Dec 21;12(12), Yang B, Ryu J, Kim T, Jo YS, Kim Y, Park HY, Kang YA, Lee SJ, Lee OJ, Moon JY, Ra SW, Kim SH, Kim TH, Kwon YS, Oh YM, Lee KM, Sohn JW, Yoon HJ, Choi H, Lee H Chest 2020 Dec 26; [Epub ahead of print], Jiang X, Wang L, Su X, Zeng W, Xu A, Zheng Q, Xu W PLoS One 2020 Dec 29;15(12):e0244238, Children's Brain Tumor Network (Authors include: Ding L) (Contributors include: Wyczalkowski MA) Cell 2020 Dec 23;183(7):1962-1985e31, Casadevall A, Grossman BJ, Henderson JP, Joyner MJ, Shoham S, Pirofski LA, Paneth N Med (N Y) 2020 Dec 18;1(1):66-77, Fontana F, Scott MJ, Allen JS, Yang X, Cui G, Pan D, Yanaba N, Fiala MA, O'Neal J, Schmieder-Atteberry AH, Ritchey J, Rettig M, Simons K, Fletcher S, Vij R, DiPersio J, Lanza G Clin Cancer Res 2020 Dec 22; [Epub ahead of print], Cottrell KA, Chiou RC, Weber JD Sci Rep 2020 Dec 17;10(1):22276, Potluri HK, Ng TL, Newton MA, Zhang J, Maher CA, Nelson PS, McNeel DG J Immunother Cancer 2020 Dec;8(2), Gu G, Tian L, Herzog SK, Rechoum Y, Gelsomino L, Gao M, Du L, Kim JA, Dustin D, Lo HC, Beyer AR, Edwards DG, Gonzalez T, Tsimelzon A, Huang HJ, Fernandez NM, Grimm SL, Hilsenbeck SG, Liu D, Xu J, Alaniz A, Li S, Mills GB, Janku F, Kittler R, Zhang XH, Coarfa C, Foulds CE, Symmans WF, Ando S, Fuqua SAW Oncogene 2020 Dec 15; [Epub ahead of print], Jacob S, Davis AA, Gerratana L, Velimirovic M, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar W, Behdad A, Bardia A, Cristofanilli M Clin Cancer Res 2020 Dec 15; [Epub ahead of print], COVID-19 and Cancer Consortium (Contributors include: Campian JL, Fiala MA, Stockerl-Goldstein KE) Cancer Cell 2020 Dec 14;38(6):761-766, Hsieh JJ Clin Genitourin Cancer 2020 Dec;18(6):423-424, Otegbeye EE, Mitchem JB, Park H, Chaudhuri A, Kim H, Md MGM, Ciorba MA Transl Res 2020 Dec 8; [Epub ahead of print], Gounder MM, Merriam P, Ratan R, Patel SR, Chugh R, Villalobos VM, Thornton M, Van Tine BA, Abdelhamid AH, Whalen J, Yang J, Rajarethinam A, Duh MS, Bobbili PJ, Huynh L, Totev TI, Lax AK, Agarwal S, Demetri GD Cancer 2020 Dec 9; [Epub ahead of print], Aktas A, Probst D, Van Tine B, Marlow K Rare Tumors 2020 Nov 25;12:2036361320977012, Ribas A, Algazi A, Ascierto PA, Butler MO, Chandra S, Gordon M, Hernandez-Aya L, Lawrence D, Lutzky J, Miller WH Jr, Campbell KM, Delafont B, Marshall S, Mueller N, Robert C Nat Commun 2020 Dec 7;11(1):6262, Gau N, Grossman BJ Transfusion 2020 Dec;60(12):2785-2786, Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Kang Y, Hultcrantz M, Larson S, Liedtke M, Martin T, Omel J, Shain K, Sborov D, Stockerl-Goldstein K, Weber D, Keller J, Kumar R J Natl Compr Canc Netw 2020 Dec 2;18(12):1685-1717, Khaddour K, Chicoine MR, Huang J, Dahiya S, Ansstas G J Natl Compr Canc Netw 2020 Dec 2;18(12):1590-1595, Fuh K, Mullen M, Blachut B, Stover E, Konstantinopoulos P, Liu J, Matulonis U, Khabele D, Mosammaparast N, Vindigni A Gynecol Oncol 2020 Dec;159(3):877-886, Slade MJ, Uy GL Best Pract Res Clin Haematol 2020 Dec;33(4):101219, Fraser GAM, Chanan-Khan A, Demirkan F, Santucci Silva R, Grosicki S, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Loscertales J, Avigdor A, Rule S, Samoilova O, Pavlovsky MA, Goy A, Mato A, Hallek M, Salman M, Tamegnon M, Sun S, Connor A, Nottage K, Schuier N, Balasubramanian S, Howes A, Cramer P Leuk Lymphoma 2020 Dec;61(13):3188-3197, England P, Hong Z, Rhea L, Hirbe A, McDonald D, Cipriano C Clin Orthop Relat Res 2020 Dec;478(12):2812-2820, Silva-Fisher J, Nervo LM, Addo T, Guerra A, Walker M, Guerrier S, McGill L, Brooks D, Joseph J, Johnson J, Ayombil F, Odinammadu K Mol Cell 2020 Dec 3;80(5):752-757, Bartlett NL Hematology Am Soc Hematol Educ Program 2020 Dec 4;2020(1):140-147, Regmi R, Srinivasan S, Latham AP, Kukshal V, Cui W, Zhang B, Bose R, Schlau-Cohen GS J Phys Chem Lett 2020 Dec 3;11(23):10037-10044, Borthakur G, Ofran Y, Tallman MS, Foran J, Uy GL, DiPersio JF, Showel MM, Shimoni A, Nagler A, Rowe JM, Altman JK, Abraham M, Peled A, Shaw S, Bohana-Kashtan O, Sorani E, Pereg Y, Foley-Comer A, Oberkovitz G, Lustig TM, Glicko-Kabir I, Aharon A, Vainstein-Haras A, Kadosh SE, Samara E, Al-Rawi AN, Pemmaraju N, Bueso-Ramos C, Cortes JE, Andreeff M Cancer 2020 Dec 3; [Epub ahead of print], Berrien-Elliott MM, Cashen AF, Cubitt CC, Neal CC, Wong P, Wagner JA, Foster M, Schappe T, Desai S, McClain E, Becker-Hapak M, Foltz JA, Cooper ML, Jaeger N, Srivatsan SN, Gao F, Romee R, Abboud CN, Uy GL, Westervelt P, Jacoby MA, Pusic I, Stockerl-Goldstein KE, Schroeder MA, DiPersio J, Fehniger TA Cancer Discov 2020 Dec;10(12):1854-1871, Welch JS Haematologica 2020 Dec 1;105(12):2708-2710, Afzal A, Fiala MA, Gage BF, Wildes TM, Sanfilippo K Clin Lymphoma Myeloma Leuk 2020 Dec;20(12):e937-e943, Pachynski RK Eur Urol 2020 Dec;78(6):831-833, Mikhael J, Richter J, Vij R, Cole C, Zonder J, Kaufman JL, Bensinger W, Dimopoulos M, Lendvai N, Hari P, Ocio EM, Gasparetto C, Kumar S, Oprea C, Chiron M, Brillac C, Charpentier E, San-Miguel J, Martin T Leukemia 2020 Dec;34(12):3298-3309, Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A Leukemia 2020 Dec;34(12):3338-3347, Flannelly C, Tan BE, Tan JL, McHugh CM, Sanapala C, Lagu T, Liesveld JL, Aljitawi O, Becker MW, Mendler JH, Klepin HD, Stock W, Wildes TM, Artz A, Majhail NS, Loh KP Biol Blood Marrow Transplant 2020 Dec;26(12):2335-2345, Shea L, Watkins MP, Wan F, Cashen AF, Wagner-Johnston ND, Jacoby MA, Abboud CN, DiPersio JF, Hurd DD, Jaglowski SM, Bartlett NL, Fehniger TA Biol Blood Marrow Transplant 2020 Dec;26(12):2223-2228, Peterson LL, Lustberg M, Tolaney SM, Ross M, Salehi E, Isakoff SJ Oncol Ther 2020 Dec;8(2):325-332, Jurczyszyn A, Waszczuk-Gajda A, Castillo JJ, Krawczyk K, Stork M, Pour L, Usnarska-Zubkiewicz L, Potoczek S, Hus I, Davila Valls J, Hari P, Chhabra S, Gentile M, Mikala G, Varga G, Chim CS, Fiala M, Vij R, Schutz N, Rodzaj M, Porowska A, Vesole DH, Druzd-Sitek A, Walewski J, Nooka AK Leuk Lymphoma 2020 Dec;61(12):2868-2875, Rosenfeld D, Alam M, Van Tine B, Council ML J Am Acad Dermatol 2020 Dec;83(6):e429-e430, Han Y, Miao ZF, Lian M, Peterson LL, Colditz GA, Liu Y Breast Cancer Res Treat 2020 Dec;184(3):915-925, Zhao K, Kim EH, Vetter JM, Hsieh JJ, Venkatesh R, Bhayani SB, Figenshau RS Mol Clin Oncol 2020 Dec;13(6):71, Borghaei H, Redman MW, Kelly K, Waqar SN, Robert F, Kiefer GJ, Stella PJ, Minichiello K, Gandara DR, Herbst RS, Papadimitrakopoulou VA Clin Lung Cancer 2020 Nov 10; [Epub ahead of print], Khaddour K, Fields RC, Ansstas M, Rosman IS, Ansstas G Hered Cancer Clin Pract 2020 Nov 16;18(1):23, Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, Lopez-Fernandez T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J CA Cancer J Clin 2020 Nov;70(6):480-504, Hassanzadeh C, Sita T, Savoor R, Samson PP, Bradley J, Gentile M, Roach M, Mohindra N, Waqar S, Kruser TJ, Robinson C J Thorac Dis 2020 Nov;12(11):6690-6700, Federico C, Alhallak K, Sun J, Duncan K, Azab F, Sudlow GP, de la Puente P, Muz B, Kapoor V, Zhang L, Yuan F, Markovic M, Kotsybar J, Wasden K, Guenthner N, Gurley S, King J, Kohnen D, Salama NN, Thotala D, Hallahan DE, Vij R, DiPersio JF, Achilefu S, Azab AK Nat Commun 2020 Nov 27;11(1):6037, Clinical Proteomic Tumor Analysis Consortium (Authors include: Cao S, Wyczalkowski MA, Ding L) (Contributors include: Li S, Maher C) Cell 2020 Nov 25;183(5):1436-1456, Jasielec JK, Kubicki T, Raje N, Vij R, Reece D, Berdeja J, Derman BA, Rosenbaum CA, Richardson P, Gurbuxani S, Major S, Wolfe B, Stefka AT, Stephens L, Tinari KM, Hycner T, Rojek AE, Dytfeld D, Griffith KA, Zimmerman TM, Jakubowiak AJ Blood 2020 Nov 26;136(22):2513-2523, Di Martino O, Niu H, Hadwiger G, Kuusanmaki H, Ferris MA, Vu A, Beales J, Wagner C, Menendez-Gutierrez MP, Ricote M, Heckman C, Welch JS Haematologica 2020 Nov 26, Gerds AT, Savona MR, Scott BL, Talpaz M, Egyed M, Harrison CN, Yacoub A, Vannucchi A, Mead AJ, Kiladjian JJ, O'Sullivan J, Garcia-Gutierrez V, Bose P, Rampal RK, Miller CB, Palmer J, Oh ST, Buckley SA, Mould DR, Ito K, Tyavanagimatt S, Smith JA, Roman-Torres K, Devineni S, Craig AR, Mascarenhas JO Blood Adv 2020 Nov 24;4(22):5825-5835, Somaiah N, Van Tine BA, Wahlquist AE, Milhem MM, Hill EG, Garrett-Mayer E, Armeson KE, Schuetze SM, Meyer CF, Reuben DY, Elias AD, Read WL, Chawla SP, Kraft AS Cancer 2020 Nov 24; [Epub ahead of print], Clifton K, Luo J, Tao Y, Saam J, Rich T, Roshal A, Frith A, Rigden C, Ademuyiwa F, Weilbaecher K, Hernandez-Aya L, Peterson LL, Bagegni N, Suresh R, Bose R, Opyrchal M, Wildes TM, Ma C Breast Cancer Res Treat 2020 Nov 20; [Epub ahead of print], Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S, Izquierdo AR, Lossos IS, Reeder C, Sher T, Chen R, Schwarz SE, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM Blood 2020 Nov 19;136(21):2401-2409, Ghosh T, Duncavage E, Mehta-Shah N, McGuire PA, Tenenbaum M, Myckatyn TM Aesthet Surg J 2020 Nov 19;40(12):1288-1300, Cadwell CR, Yuksek GE, Hirbe AC, Srihari D, LeBoit P, Dahiya S, Pekmezci M J Neuropathol Exp Neurol 2020 Nov 19; [Epub ahead of print], Zhang KW, Zhang R, Deych E, Stockerl-Goldstein KE, Gorcsan J 3rd, Lenihan DJ Am Heart J 2020 Nov 16; [Epub ahead of print], Hamadani M, Radford J, Carlo-Stella C, Caimi PF, Reid EG, O'Connor OA, Feingold J, Ardeshna KM, Townsend WM, Solh M, Heffner LT, Ungar D, Wang L, Boni JP, Havenith K, Qin YG, Kahl B Blood 2020 Nov 19; [Epub ahead of print], Doray B, Liu L, Lee WS, Jennings BC, Kornfeld S FEBS Open Bio 2020 Nov 18; [Epub ahead of print], Hellmann MD, Janne PA, Opyrchal M, Hafez N, Raez LE, Gabrilovich DI, Wang F, Trepel JB, Lee MJ, Yuno A, Lee S, Brouwer S, Sankoh S, Wang L, Tamang D, Schmidt EV, Meyers ML, Ramalingam SS, Shum E, Ordentlich P Clin Cancer Res 2020 Nov 17; [Epub ahead of print], Khaddour K, Johanns TM, Ansstas G Pharmaceuticals (Basel) 2020 Nov 14;13(11), Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C J Clin Oncol 2020 Nov 20;38(33):3925-3936, Sachdev JC, Munster P, Northfelt DW, Han HS, Ma C, Maxwell F, Wang T, Belanger B, Zhang B, Moore Y, Thiagalingam A, Anders C Breast Cancer Res Treat 2020 Nov 17; [Epub ahead of print], Nagaraj G, Ma CX Adv Ther 2020 Nov 15; [Epub ahead of print], Martin-Broto J, Moura DS, Van Tine BA Clin Cancer Res 2020 Nov 15;26(22):5801-5808, Gang M, Marin ND, Wong P, Neal CC, Marsala L, Foster M, Schappe T, Meng W, Tran J, Schaettler M, Davila M, Gao F, Cashen AF, Bartlett NL, Mehta-Shah N, Kahl BS, Kim MY, Cooper ML, DiPersio JF, Berrien-Elliott MM, Fehniger TA Blood 2020 Nov 12;136(20):2308-2318, Lanigan LG, Hildreth BE 3rd, Dirksen WP, Simmons JK, Martin CK, Werbeck JL, Thudi NK, Papenfuss TL, Boyaka PN, Toribio RE, Ward JM, Weilbaecher KN, Rosol TJ Am J Pathol 2020 Nov 9; [Epub ahead of print], Tirman S, Cybulla E, Quinet A, Meroni A, Vindigni A Crit Rev Biochem Mol Biol 2020 Nov 12:1-14, Ghai A, Zheleznyak A, Mixdorf M, O'Neal J, Ritchey J, Rettig M, DiPersio J, Shokeen M, Achilefu S Eur J Nucl Med Mol Imaging 2020 Nov 11; [Epub ahead of print], Khaddour K, Rosman IS, Dehdashti F, Ansstas G J Dermatol 2020 Nov 7; [Epub ahead of print], Park H, Williams K, Trikalinos NA, Larson S, Tan B, Waqar S, Suresh R, Morgensztern D, Van Tine BA, Govindan R, Luo J, Lockhart AC, Wang-Gillam A Cancer Chemother Pharmacol 2020 Nov 6; [Epub ahead of print], Spiegel JY, Dahiya S, Jain MD, Tamaresis JS, Nastoupil L, Jacobs MT, Ghobadi A, Lin Y, Lunning M, Lekakis LJ, Reagan P, Oluwole OO, McGuirk JP, Deol A, Goy A, Vu K, Andreadis C, Munoz J, Bennani NN, Vose J, Dorritie KA, Neelapu SS, Locke FL, Rapoport AP, Hill B, Miklos DB Blood 2020 Nov 6; [Epub ahead of print], Cardio-Oncology Leadership Council (Authors include: Stockerl-Goldstein K) J Am Coll Cardiol 2020 Nov 10;76(19):2267-2281, Lee JC, Shin DW, Park H, Kim J, Youn Y, Kim JH, Kim J, Hwang JH Gastrointest Endosc 2020 Nov;92(5):1044-1052, Liu M, Kuo F, Capistrano KJ, Kang D, Nixon BG, Shi W, Chou C, Do MH, Stamatiades EG, Gao S, Li S, Chen Y, Hsieh JJ, Hakimi AA, Taniuchi I, Chan TA, Li MO Nature 2020 Nov;587(7832):115-120, Gounder M, Schoffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, Attia S, Chugh R, Chen TW, Jahan T, Loggers ET, Gupta A, Italiano A, Demetri GD, Ratan R, Davis LE, Mir O, Dileo P, Van Tine BA, Pressey JG, Lingaraj T, Rajarethinam A, Sierra L, Agarwal S, Stacchiotti S Lancet Oncol 2020 Nov;21(11):1423-1432, Jhaveri K, Chang MT, Juric D, Saura C, Gambardella V, Melnyk A, Patel MR, Ribrag V, Ma CX, Aljumaily R, Bedard PL, Sachdev JC, Dunn L, Won HH, Bond J, Jones S, Savage HM, Scaltriti M, Wilson TR, Wei MC, Hyman DM Clin Cancer Res 2020 Nov 4; [Epub ahead of print], Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H J Natl Compr Canc Netw 2020 Nov 2;18(11):1460-1467, Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler JS, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve DC, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow SD J Natl Compr Canc Netw 2020 Nov 2;18(11):1537-1570, Cao S, Zhou DC, Oh C, Jayasinghe RG, Zhao Y, Yoon CJ, Wyczalkowski MA, Bailey MH, Tsou T, Gao Q, Malone A, Reynolds S, Shmulevich I, Wendl MC, Chen F, Ding L Nat Commun 2020 Nov 4;11(1):5573, Training Residents in Genomics (TRIG) Working Group (Contributors include: Devarakonda S) Am J Clin Pathol 2020 Nov 4;154(6):784-791, Janku F, Park H, Call SG, Madwani K, Oki Y, Subbiah V, Hong DS, Naing A, Velez-Bravo VM, Barnes TG, Hagemeister FB, Falchook GS, Karp DD, Wheler JJ, Piha-Paul SA, Garrido-Laguna I, Shpall EJ, Fayad LE, Neelapu SS, Meric-Bernstam F, Kurzrock R, Fanale MA Clin Cancer Res 2020 Nov 1;26(21):5579-5587, Bueno R, Richards WG, Harpole DH, Ballman KV, Tsao MS, Chen Z, Wang X, Chen G, Chirieac LR, Chui MH, Franklin WA, Giordano TJ, Govindan R, Joshi MB, Merrick DT, Rivard CJ, Sporn T, van Bokhoven A, Yu H, Shepherd FA, Watson MA, Beer DG, Hirsch FR J Thorac Oncol 2020 Nov;15(11):1748-1757, Abboud R, Slade M, Abboud C, DiPersio JF Leuk Lymphoma 2020 Nov 2:1-3; [Epub ahead of print], Nazha A, Hu ZH, Wang T, Lindsley RC, Abdel-Azim H, Aljurf M, Bacher U, Bashey A, Cahn JY, Cerny J, Copelan E, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla SM, Gale RP, George B, Gergis U, Grunwald MR, Hamilton B, Hashmi S, Hildebrandt GC, Inamoto Y, Kalaycio M, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Liesveld JL, Litzow MR, Majhail NS, Murthy HS, Nathan S, Nishihori T, Pawarode A, Rizzieri D, Sabloff M, Savani BN, Schachter L, Schouten HC, Seo S, Shah NN, Solh M, Valcarcel D, Vij R, Warlick E, Wirk B, Wood WA, Yared JA, Alyea E, Popat U, Sobecks RM, Scott BL, Nakamura R, Saber W Biol Blood Marrow Transplant 2020 Nov;26(11):2139-2146, Mian H, Pond GR, Tuchman SA, Fiala MA, Wildes TM J Geriatr Oncol 2020 Nov;11(8):1279-1284, Fiala MA, Foley NC, Zweegman S, Vij R, Wildes TM J Geriatr Oncol 2020 Nov;11(8):1274-1278, Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, Patel M, Berthon A, Syed A, Yabe M, Coombs CC, Caltabellotta NM, Walsh M, Offit K, Stadler Z, Mandelker D, Schulman J, Patel A, Philip J, Bernard E, Gundem G, Ossa JEA, Levine M, Martinez JSM, Farnoud N, Glodzik D, Li S, Robson ME, Lee C, Pharoah PDP, Stopsack KH, Spitzer B, Mantha S, Fagin J, Boucai L, Gibson CJ, Ebert BL, Young AL, Druley T, Takahashi K, Gillis N, Ball M, Padron E, Hyman DM, Baselga J, Norton L, Gardos S, Klimek VM, Scher H, Bajorin D, Paraiso E, Benayed R, Arcila ME, Ladanyi M, Solit DB, Berger MF, Tallman M, Garcia-Closas M, Chatterjee N, Diaz LA Jr, Levine RL, Morton LM, Zehir A, Papaemmanuil E Nat Genet 2020 Nov;52(11):1219-1226, Alahmari B, Cooper ML, Vij K, Ritchey J, Ruminski P, Gao F, Choi J, DiPersio JF Leukemia 2020 Nov;34(11):3100-3104, Chrisinger JSA, Wehrli B, Dickson BC, Fasih S, Hirbe AC, Shultz DB, Zadeh G, Gupta AA, Demicco EG Virchows Arch 2020 Nov;477(5):725-732, Cheson BD, Bartlett NL, LaPlant B, Lee HJ, Advani RJ, Christian B, Diefenbach CS, Feldman TA, Ansell SM Lancet Haematol 2020 Nov;7(11):e808-e815, Clements JL, Pohl F, Muthupandi P, Rogers SC, Mao J, Doctor A, Birman VB, Held JM Redox Biol 2020 Oct;37:101707, Andruska N, Mahapatra L, Brenneman R, Hernandez-Aya LF, MacArthur KM, Baumann BC J Dermatol 2020 Oct;47(10):e375-e376, Baumann BC, Bernstein KA, DeLaney TF, Simone CB 2nd, Kolker JD, Choy E, Levin WP, Weber KL, Muniappan A, Berman AT, Staddon A, Hartner L, Van Tine B, Hirbe A, Glatstein E, Hahn SM, Nagda SN, Chen YL J Surg Oncol 2020 Oct;122(5):877-883, Munroe M, Niero EL, Fok WC, Vessoni AT, Jeong HC, Brenner KA, Batista LFZ Hepatology 2020 Oct;72(4):1412-1429, Gang M, Wong P, Berrien-Elliott MM, Fehniger TA Semin Hematol 2020 Oct;57(4):185-193, Yang JJ, So N, Maloney NJ, Arzeno J, Clifton KK, Bach DQ J Am Acad Dermatol 2020 Oct 23; [Epub ahead of print], Waqar SN, Redman MW, Arnold SM, Hirsch FR, Mack PC, Schwartz LH, Gandara DR, Stinchcombe TE, Leighl NB, Ramalingam SS, Tanna SH, Raddin RS, Minichiello K, Bradley JD, Kelly K, Herbst RS, Papadimitrakopoulou VA Clin Lung Cancer 2020 Oct 14; [Epub ahead of print], Hensing W, Santa-Maria CA, Peterson LL, Sheng JY Semin Oncol 2020 Oct;47(5):278-292, Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ medRxiv 2020 Oct 29, Sohani AR, Maurer MJ, Giri S, Pitcher B, Chadburn A, Said JW, Bartlett NL, Czuczman MS, Martin P, Rosenbaum CA, Jung SH, Leonard JP, Cheson BD, Hsi ED Am J Surg Pathol 2020 Oct 30; [Epub ahead of print], Schoen MW, Carson KR, Luo S, Gage BF, Li A, Afzal A, Sanfilippo KM Res Pract Thromb Haemost 2020 Sep 25;4(7):1203-1210, Wood M, Quinet A, Lin YL, Davis AA, Pasero P, Ayala YM, Vindigni A J Cell Sci 2020 Oct 30;133(20), Tumor Neoantigen Selection Alliance (Authors include: Ward JP) (Contributors include: Miller CA) Cell 2020 Oct 29;183(3):818-834e13, Bulle A, Lim KH Signal Transduct Target Ther 2020 Oct 30;5(1):249, Mian HS, Seow H, Wildes TM, Kouroukis CT, Pond GR, Sivapathasundaram B, Sussman J J Geriatr Oncol 2020 Oct 24; [Epub ahead of print], Mascarenhas JO, Rampal RK, Kosiorek HE, Bhave R, Hexner E, Wang ES, Gerds A, Abboud CN, Kremyanskaya M, Berenzon D, Odenike O, Farnoud N, Krishnan A, Weinberg RS, McGovern E, Salama ME, Najfeld V, Medina-Martinez JS, Arango Ossa JE, Levine MF, Zhou Y, Sandy L, Heaney ML, Levine RL, Mesa RA, Dueck AC, Hoffman R Blood Adv 2020 Oct 27;4(20):5246-5256, Mian HS, Fiala MA, Wildes TM Clin Lymphoma Myeloma Leuk 2020 Oct 1; [Epub ahead of print], Krishnamoorthy S, Ghobadi A, Delos Santos R, Schilling JD, Malone AF, Murad H, Bartlett NL, Alhamad T Am J Transplant 2020 Oct 22; [Epub ahead of print], Dimopoulos MA, Bringhen S, Anttila PM, Capra M, Cavo M, Cole CE, Gasparetto C, Hungria VTM, Jenner MW, Vorobyev VI, Yanez Ruiz EP, Yin JY, Saleem R, Hellet M, Mace S, Paiva B, Vij R Blood 2020 Oct 20; [Epub ahead of print], Levitin M, Ofori J, Shin WJ, Huang J, Daly M, Cao D, Pachynski R Front Oncol 2020 Sep 23;10:566070, Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, Margolin K, Awad MM, Hellmann MD, Lin JJ, Friedlander T, Bushway ME, Balogh KN, Sciuto TE, Kohler V, Turnbull SJ, Besada R, Curran RR, Trapp B, Scherer J, Poran A, Harjanto D, Barthelme D, Ting YS, Dong JZ, Ware Y, Huang Y, Huang Z, Wanamaker A, Cleary LD, Moles MA, Manson K, Greshock J, Khondker ZS, Fritsch E, Rooney MS, DeMario M, Gaynor RB, Srinivasan L Cell 2020 Oct 15;183(2):347-362e24, Vadakekolathu J, Lai C, Reeder S, Church SE, Hood T, Lourdusamy A, Rettig MP, Aldoss I, Advani AS, Godwin J, Wieduwilt MJ, Arellano M, Muth J, Yau TO, Ravandi F, Sweet K, Altmann H, Foulds GA, Stolzel F, Middeke JM, Ciciarello M, Curti A, Valk PJM, Lowenberg B, Gojo I, Bornhauser M, DiPersio JF, Davidson-Moncada JK, Rutella S Blood Adv 2020 Oct 27;4(20):5011-5024, Tam CS, Robak T, Ghia P, Kahl BS, Walker P, Janowski W, Simpson D, Shadman M, Ganly PS, Laurenti L, Opat S, Tani M, Ciepluch H, Verner E, Simkovic M, Osterborg A, Trneny M, Tedeschi A, Paik JC, Kuwahara SB, Feng S, Ramakrishnan V, Cohen A, Huang J, Hillmen P, Brown JR Haematologica 2020 Oct 13;Online ahead of print, Krisnawan VE, Stanley JA, Schwarz JK, DeNardo DG Cancers (Basel) 2020 Oct 11;12(10), Ye Z, Price RL, Liu X, Lin J, Yang Q, Sun P, Wu AT, Wang L, Han RH, Song C, Yang R, Gary SE, Mao DD, Wallendorf M, Campian JL, Li J, Dahiya S, Kim AH, Song SK Clin Cancer Res 2020 Oct 15;26(20):5388-5399, Sharma P, Pachynski RK, Narayan V, Flechon A, Gravis G, Galsky MD, Mahammedi H, Patnaik A, Subudhi SK, Ciprotti M, Simsek B, Saci A, Hu Y, Han GC, Fizazi K Cancer Cell 2020 Oct 12;38(4):489-499, Yu Y, Brown Wade N, Hwang AE, Nooka AK, Fiala MA, Mohrbacher A, Peters ES, Pawlish K, Bock C, Van Den Berg DJ, Rand KA, Stram D, Conti DV, Auclair D, Colditz GA, Mehta J, Haiman CA, Terebelo H, Janakiraman N, Singhal S, Chiu B, Vij R, Bernal-Mizrachi L, Zonder JA, Huff CA, Lonial S, Orlowski RZ, Cozen W, Ailawadhi S JCO Oncol Pract 2020 Oct;16(10):e1169-e1180, Loh KP, Abdallah M, Kadambi S, Wells M, Kumar AJ, Mendler JH, Liesveld JL, Wittink M, O'Dwyer K, Becker MW, McHugh C, Stock W, Majhail NS, Wildes TM, Duberstein P, Mohile SG, Klepin HD Leuk Lymphoma 2020 Oct 11:1-12; [Epub ahead of print], Popli P, Richters MM, Chadchan SB, Kim TH, Tycksen E, Griffith O, Thaker PH, Griffith M, Kommagani R Cell Death Dis 2020 Oct 10;11(10):842, Locke FL, Rossi JM, Neelapu SS, Jacobson CA, Miklos DB, Ghobadi A, Oluwole OO, Reagan PM, Lekakis LJ, Lin Y, Sherman M, Better M, Go WY, Wiezorek JS, Xue A, Bot A Blood Adv 2020 Oct 13;4(19):4898-4911, Russler-Germain DA, Watkins MP, Bartlett NL Leuk Lymphoma 2020 Oct 8:1-3; [Epub ahead of print], Le BV, Podszywalow-Bartnicka P, Maifrede S, Sullivan-Reed K, Nieborowska-Skorska M, Golovine K, Yao JC, Nejati R, Cai KQ, Caruso LB, Swatler J, Dabrowski M, Lian Z, Valent P, Paietta EM, Levine RL, Fernandez HF, Tallman MS, Litzow MR, Huang J, Challen GA, Link D, Tempera I, Wasik MA, Piwocka K, Skorski T Cell Rep 2020 Oct 6;33(1):108221, Deininger MW, Shah NP, Altman JK, Berman E, Bhatia R, Bhatnagar B, DeAngelo DJ, Gotlib J, Hobbs G, Maness L, Mead M, Metheny L, Mohan S, Moore JO, Naqvi K, Oehler V, Pallera AM, Patnaik M, Pratz K, Pusic I, Rose MG, Smith BD, Snyder DS, Sweet KL, Talpaz M, Thompson J, Yang DT, Gregory KM, Sundar H J Natl Compr Canc Netw 2020 Oct 1;18(10):1385-1415, Fiala MA, Wildes TM, Vij R Clin Lymphoma Myeloma Leuk 2020 Oct;20(10):647-651, Cancilla D, Rettig MP, DiPersio JF Front Oncol 2020 Sep 4;10:1672, Reimers MA, Figenshau RS, Kim EH, Tucker J, Kasten N, Khan AS, Hanneken JM, Smith ZL, Hsieh JJ Clin Genitourin Cancer 2020 Oct;18(5):361-366, Hsieh JJ Clin Genitourin Cancer 2020 Oct;18(5):341-342, Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, Spies NC, Lin T, Li T, Mulder DT, Hanna Y, Cirlan I, Pugh TJ, Mudianto T, Riley R, Zhou L, Jo VY, Stachler MD, Hanna GJ, Kass J, Haddad R, Schoenfeld JD, Gjini E, Lako A, Thorstad W, Gay HA, Daly M, Rodig SJ, Hagemann IS, Kallogjeri D, Piccirillo JF, Chernock RD, Griffith M, Griffith OL, Adkins DR Clin Cancer Res 2020 Oct 1;26(19):5140-5152, Wu AA, Bever KM, Ho WJ, Fertig EJ, Niu N, Zheng L, Parkinson RM, Durham JN, Onners B, Ferguson AK, Wilt C, Ko AH, Wang-Gillam A, Laheru DA, Anders RA, Thompson ED, Sugar EA, Jaffee EM, Le DT Clin Cancer Res 2020 Oct 1;26(19):5129-5139, Challen GA, Goodell MA Blood 2020 Oct 1;136(14):1590-1598, Warren JT, Link DC Blood 2020 Oct 1;136(14):1599-1605, Cancer and Aging Research Group (CARG) (Authors include: Wildes TM) CA Cancer J Clin 2020 Oct 1; [Epub ahead of print], Ghione P, Faruque P, Mehta-Shah N, Seshan V, Ozkaya N, Bhaskar S, Yeung J, Spinner MA, Lunning M, Inghirami G, Moskowitz A, Galasso N, Ganesan N, van der Weyden C, Ruan J, Prince HM, Trotman J, Advani R, Dogan A, Horwitz S Blood Adv 2020 Oct 13;4(19):4640-4647, DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY Lancet Haematol 2020 Oct;7(10):e724-e736, Westervelt P Lancet Haematol 2020 Oct;7(10):e698-e699, Ha CS, LeBlanc M, Schoder H, Pinnix CC, Bartlett NL, Evens AM, Hsi ED, Rimsza L, Knopp MV, Zhang J, Leonard JP, Kahl BS, Li H, Smith S, Constine LS, Friedberg JW Leuk Lymphoma 2020 Oct;61(10):2442-2447, Uy GL, Assouline S, Young AM, Blotner S, Higgins B, Chen LC, Yee K Invest New Drugs 2020 Oct;38(5):1430-1441, Ritter M, Klimiankou M, Klimenkova O, Schambach A, Hoffmann D, Schmidt A, Kanz L, Link DC, Welte K, Skokowa J Ann Hematol 2020 Oct;99(10):2329-2338, Guy D, Kahl BS Hematol Oncol Clin North Am 2020 Oct;34(5):861-870, Singh N, Orlando E, Xu J, Xu J, Binder Z, Collins MA, O'Rourke DM, Melenhorst JJ Semin Cancer Biol 2020 Oct;65:91-98, Dodhiawala PB, Khurana N, Zhang D, Cheng Y, Li L, Wei Q, Seehra K, Jiang H, Grierson PM, Wang-Gillam A, Lim KH J Clin Invest 2020 Jun 23; [Epub ahead of print], Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, Fields RC, DeSelm CJ, Schwarz JK, DeNardo DG Cancer Cell 2020 Mar 16;37(3):289-307e9, NHGRI Centers for Common Disease Genomics (Authors include: Hall IM) Nature 2020 May 27; [Epub ahead of print], Dege C, Fegan KH, Creamer JP, Berrien-Elliott MM, Luff SA, Kim D, Wagner JA, Kingsley PD, McGrath KE, Fehniger TA, Palis J, Sturgeon CM Dev Cell 2020 Apr 20;53(2):229-239e7, Zhu J, Muia J, Gupta G, Westfield LA, Vanhoorelbeke K, Tolia NH, Sadler JE Blood 2019 Apr 25;133(17):1909-1918, Fok WC, Shukla S, Vessoni AT, Brenner KA, Parker R, Sturgeon CM, Batista LFZ Blood 2019 Feb 6; [Epub ahead of print], Duncavage EJ, Jacoby MA, Chang GS, Miller CA, Edwin N, Shao J, Elliott K, Robinson J, Abel H, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Brendel K, Saba R, Wartman LD, Christopher MJ, Pusic I, Welch JS, Uy GL, Link DC, DiPersio JF, Westervelt P, Ley TJ, Trinkaus K, Graubert TA, Walter MJ N Engl J Med 2018 Sep 13;379(11):1028-1041, Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF Leukemia 2018 Sep;32(9):1970-1983, Angelo Brunelli (Stephen Oh lab): "Pevonedistat Targets Malignant Cells in Myeloproliferative Neoplasms in Vitro and in Vivo Via NFkB Pathway Inhibition", Michael Slade: "Treatment of Acquired Aplastic Anemia", Jing Xi: "Myeloid Sarcoma: The Other Side of Acute Leukemia", Michael Deininger, MD, PhD (Huntsman Cancer Institute, University of Utah): "A Critical Role for SIRT5 in Acute Myeloid Leukemia Metabolism", Ron Bose, MD, PhD: "HER2 Activating Mutations in Breast and Colorectal Cancer", Joseph Ippolito, MD, PhD: "Characterizing Sex Differences in Cancer Cell Nutrient Consumption", Jacqueline Payton: "Discoveries in Epigenomics Drive Precision Medicine Approaches in Lymphoma", Dilan Patel: "Bone Marrow Transplant in Sickle Cell Disease", Huntsman Cancer Institute, University of Utah, Hematology Research / Work-in-Progress Seminar, Mechanisms in Cancer Biology Research Forum, K12 Paul Calabresi Career Development Program in Clinical Oncology, T32 Training Program in Molecular Hematology, Adult Hemophilia and Bleeding Disorders Center, Center for Gene and Cellular Immunotherapy, Science Translational Medicine 2019 Jul 3, Journal of Translational Medicine 2018 May 29, Journal of Experimental Medicine 2017 Sep 5, New England Journal of Medicine 2016 Nov 24, Science Translational Medicine 2016 Sep 21.